Management of acute bronchospasm in pediatric populations

Bradley E Chipps1

  • 1Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA. bchipps@capitalallergy.com

Postgraduate Medicine
|August 12, 2009
PubMed

Insights

Identifying children at risk for severe asthma attacks is crucial. Peak expiratory flow (PEF), FEV1, and SaO2 can predict exacerbation severity and hospitalization needs in pediatric asthma patients.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Asthma impacts over 6 million children in the US, necessitating early identification of severe exacerbation risks.
  • Recognizing children prone to life-threatening bronchospasm is critical for timely intervention.

Purpose of the Study:

  • To highlight the predictive value of key respiratory parameters in pediatric asthma exacerbations.
  • To present clinical data on levalbuterol's safety and efficacy in children.

Main Methods:

  • Review of clinical data focusing on peak expiratory flow (PEF), forced expiratory flow in 1 second (FEV1), and arterial oxygen saturation (SaO2).
  • Analysis of these parameters as predictors for exacerbation severity, airflow obstruction, and hospitalization.
  • Inclusion of safety and efficacy data for levalbuterol in pediatric patients.

Main Results:

  • PEF, FEV1, and SaO2 are important indicators for predicting asthma exacerbation severity.
  • These metrics help assess the degree of airflow obstruction and the likelihood of hospitalization.
  • Levalbuterol demonstrates safety and efficacy in the pediatric asthma population.

Conclusions:

  • Key respiratory measurements are vital for managing pediatric asthma exacerbations.
  • Levalbuterol is a viable treatment option for children with asthma.
  • Early identification of at-risk children can improve outcomes.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
874